... over-expressed in more than one-third of all solid tumors[20]. During cancer progression, increased shedding of the membrane-anchored ligands of EGFR, includingheparin-binding EGF (HB-EGF), transforming ... DX-2400, against the catalyticdomain of MMP-14 was designed with high bindingaffinity [84,85]. To further increase the specificity of MMPIs, the future of drug development comprises the use of drugs ... by letrozole in a dose-dependent fashion, limit-ing the metastatic potential of these cells [72]. The above observation is in accordance with the resultsobtained in the British International...